Inhibition of platelet adenylate cyclase by 1-O-alkyl-2-O-acetyl-sn-glyceryl-3-phosphorylcholine (platelet-activating factor).
D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology; D000244:Adenosine Diphosphate / Q000494:pharmacology; D000067956:Adenylyl Cyclase Inhibitors; D000262:Adenylyl Cyclases / Q000097:blood*; D000527:Alprostadil; D000818:Animals; D001792:Blood Platelets / Q000187:drug effects / Q000201:enzymology*; D003402:Creatine Kinase / Q000378:metabolism; D000242:Cyclic AMP / Q000097:blood; D007213:Indomethacin / Q000494:pharmacology; D008244:Lysophosphatidylcholines / Q000494:pharmacology*; D010725:Phosphocreatine / Q000494:pharmacology; D010972:Platelet Activating Factor; D011458:Prostaglandins E / Q000494:pharmacology; D011817:Rabbits
D000067956:Adenylyl Cyclase Inhibitors; D008244:Lysophosphatidylcholines; D010972:Platelet Activating Factor; D011458:Prostaglandins E; D010725:Phosphocreatine; D000244:Adenosine Diphosphate; D000242:Cyclic AMP; D003402:Creatine Kinase; D000262:Adenylyl Cyclases; D000527:Alprostadil; D015056:1-Methyl-3-isobutylxanthine; D007213:Indomethacin